Chronic hepatitis B, antiviral treatment
Showing 1 - 25 of >10,000
Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
Not yet recruiting
- Hepatitis B, Chronic
- Exposure factors
- (no location specified)
Sep 10, 2023
Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)
Recruiting
- Chronic HBV Infection
- Peginterferon alfa-2b combined and ETV
-
Shenzhen, ChinaShenzhen Third People Hospital
Mar 19, 2023
Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)
Active, not recruiting
- Chronic Hepatitis B
- NrtIs
- +2 more
-
Guangzhou, Guangdong, ChinaNanfang Hospital, Southern Medical University
Apr 20, 2023
Metabolic Syndrome on Antiviral Response in People With Chronic
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Jan 21, 2023
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023
Chronic Hepatitis B Trial in Seoul (Standard of care)
Active, not recruiting
- Chronic Hepatitis B
- Standard of care
-
Seoul, Korea, Republic of
- +3 more
Mar 29, 2023
Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)
Active, not recruiting
- Chronic Hepatitis B and Hepatitis D Co-infection
- HH-003 20mg/kg
- HH-003 3mg/kg
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Dec 30, 2022
After Long-Term Antiviral Treatment for Chronic Hepatitis B
Completed
- Chronic Hepatitis B e Antigen Positive
- Chronic Hepatitis B e Antigen Negative
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Hepatitis b Virus Trial in New York (HepB mAb19, Sterile Saline)
Not yet recruiting
- Hepatitis b Virus
- HepB mAb19
- Sterile Saline
-
New York, New York
- +1 more
May 12, 2023
Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)
Not yet recruiting
- Chronic Hepatitis b
- STSG-0002 Injection
-
Beijing, Beijing, China
- +3 more
Mar 6, 2023
Chronic Hepatitis b Trial in Beijing, Chongqing (STSG-0002 Injection)
Not yet recruiting
- Chronic Hepatitis b
- STSG-0002 Injection
-
Beijing, Beijing, China
- +3 more
Mar 6, 2023
HBeAg-negative CHB Patients With Indeterminate Phase
Recruiting
- Chronic Hepatitis b
- Observation
- Antiviral treatment
-
Changzhou, Jiangsu, China
- +4 more
Dec 21, 2022
Hepatitis B, Chronic Trial in Guangzhou, Changchun (Freethiadine tablets(part I), Freethiadine tablets (part II), Freethiadine
Recruiting
- Hepatitis B, Chronic
- Freethiadine tablets(part I)
- +3 more
-
Guangzhou, Guangdong, China
- +1 more
May 20, 2022
Hepatitis B, Chronic Trial in Daegu, Seoul, Ulsan (Stop group)
Recruiting
- Hepatitis B, Chronic
- Stop group
-
Daegu, Korea, Republic of
- +9 more
May 11, 2022
Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,
Recruiting
- Chronic HBV Infection
- Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
- +2 more
-
Beijing, Beijing, China
- +7 more
Feb 23, 2023
Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)
Recruiting
- Chronic Hepatitis B Virus Infection
- Entecavir
- Entecavir combined with Tenofovir Amibufenamide
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
May 15, 2022
Hepatitis B, Chronic Trial in Gothenburg (Stopping)
Not yet recruiting
- Hepatitis B, Chronic
- Stopping
-
Gothenburg, VGR, SwedenInfectious Diseases Clinic, Sahlgrenska University Hospital
Apr 13, 2022
Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)
Recruiting
- Hepatitis B Virus Infection
- Standard antiviral therapy
-
Changsha, Hunan, ChinaDepartment of Infectious Disease, Xiangya Hospital, Central Sout
May 22, 2022
Steatohepatitis in Chronic Hepatitis B
Completed
- Fatty Liver
- Chronic Hepatitis b
- Antiviral Agents
-
Bangkoknoi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital
Mar 30, 2022
System of Clinical Endpoint Events for Chronic Hepatitis B
Active, not recruiting
- Chronic Hepatitis b
-
Beijing, Beijing, China
- +6 more
Sep 2, 2022
Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)
Terminated
- Hepatitis B, Chronic
- Granulocyte Macrophage-colony Stimulating Factor
- Entecavir
-
Beijing, Beijing, China302 Military Hospital
Mar 9, 2022
Hepatitis B, Chronic, Adherence, Medication, Quality of Life Trial (effectiveness of education)
Not yet recruiting
- Hepatitis B, Chronic
- +2 more
- effectiveness of education
- (no location specified)
Mar 17, 2022